The Rising Popularity of Antibody-Drug Conjugates, with Challenges
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
All Posts
C4 Therapeutics and Merck Collaborate on Innovative Cancer Treatment
In a recent move in the biotechnology sector, C4 Therapeutics, Inc. (C4T) has announced a collaboration with pharmaceutical giant Merck …
LegoChem Biosciences Strikes Licensing Deal with Janssen for ADC Development
In a new development in the field of cancer treatment, LegoChem Biosciences, Inc., a South Korean biopharmaceutical firm, has announced …
Addressing Inequity in Medical Research: The Need to Expand Genomic Databases
Precision medicine is fast developing, with genomics being a particularly promising field. As genomic medicine advances, we get steadily closer …
Unnatural Products Secures $32M to Advance Drug Development with AI-Enhanced Macrocycles
Santa Cruz-based biotech company, Unnatural Products, Inc. (UNP), has recently secured a significant investment of $32 million in its Series …
SiSaf Advances in Alopecia Treatment with Phase II Trial of Bio-Courier® Technology
In a new development in the field of dermatological therapeutics, SiSaf Ltd, a biopharmaceutical company based in Guildford, UK, has …
Vandria Gains Momentum with $20.6M Funding to Propel Novel CNS and Mitochondrial Therapies
Vandria SA, a Swiss biotechnology firm specializing in mitochondrial therapeutics, recently announced a significant milestone in its journey. The company …
ACSR Partners with Proscia to Accelerate Global HIV Cancer Research Through Advanced Digital Pathology Platform
In a recent development for the scientific community, the AIDS and Cancer Specimen Resource (ACSR) has enhanced its ability to …
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Tech-First Companies Take the Lead in AI Drug Discovery
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …